Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Corrigendum to: CXCL1–CXCR2 axis mediates angiotensin II-induced cardiac hypertrophy and remodelling through regulation of monocyte infiltration

Corrigendum to: CXCL1–CXCR2 axis mediates angiotensin II-induced cardiac hypertrophy and... Editorial 49 shortening but protects mitochondrial function under oxidative stress. J Cell Sci protection—led to induction of telomerase activity, both its canonic- 2008;121:1046–1053. al (telomere length increase), as well as non-canonical (NO gener- 10. Bennaceur K, Atwill M, Al Zhrany N, Hoffmann J, Keavney B, Breault D, ation) functions. The authors concluded that their study identified Richardson G, von Zglinicki T, Saretzki G, Spyridopoulos I. Atorvastatin induces T cell proliferation by a telomerase reverse transcriptase (TERT) mediated telomerase activity and telomere length as sensitive cellular parame- mechanism. Atherosclerosis 2014;236:312–320. ters to measure preventive effects of exercise interventions. 11. Richardson GD, Sage A, Bennaceur K, Al Zhrany N, Coelho-Lima J, Dookun Although this may be a rather expensive way to monitor the benefi- . E, Draganova L, Saretzki G, Breault DT, Mallat Z, Spyridopoulos I. Telomerase mediates lymphocyte proliferation but not the atherosclerosis- cial exercise effects on the human body, the study findings clearly suppressive potential of regulatory T-cells. Arterioscler Thromb Vasc Biol 2018; underline the advantage of aerobic endurance training compared 38:1283–1296. with resistance training in cardiovascular ageing. . 12. Beyer AM, Freed JK, Durand MJ, Riedel M, Ait-Aissa K, Green P, Hockenberry JC, Morgan RG, Donato AJ, Peleg R, Gasparri M, Rokkas CK, Santos JH, Priel E, Conflict of interest: I.S. receives grants from TA Science New Gutterman DD. Critical role for telomerase in the mechanism of flow-mediated . dilation in the human microcirculation. Circ Res 2016;118:856–866. York. I.S. and K.S. receive fees for being on the regional advisory 13. Sarin KY, Cheung P, Gilison D, Lee E, Tennen RI, Wang E, Artandi MK, Oro AE, board for Bayer. Artandi SE. Conditional telomerase induction causes proliferation of hair follicle stem cells. Nature 2005;436:1048–1052. . 14. Park JI, Venteicher AS, Hong JY, Choi J, Jun S, Shkrel, M, Chang, W, Meng Z, References . Cheung P, Ji H, McLaughlin M, Veenstra TD, Nusse R, McCrea PD, Artandi SE. 1. Ait-Aissa K, Ebben JD, Kadlec AO, Beyer AM. Friend or foe? Telomerase as a Telomerase modulates Wnt signalling by association with target gene chromatin. pharmacological target in cancer and cardiovascular disease. Pharmacol Res 2016; . Nature 2009;460:66–72. 111:422–433. . 15. MaidaY,YasukawaM,FuruuchiM,LassmannT,Possemato R, OkamotoN, 2. Haendeler J, Drose S, Buchner N, Jakob S, Altschmied J, Goy C, Spyridopoulos I, Kasim V, Hayashizaki Y, Hahn WC, Masutomi K. An RNA-dependent RNA Zeiher AM, Brand, U, Dimmeler S. Mitochondrial telomerase reverse transcript- polymerase formed by TERT and the RMRP RNA. Nature 2009;461: ase binds to and protects mitochondrial DNA and function from damage. . 230–235. Arterioscler Thromb Vasc Biol 2009;29:929–935. 16. Kovalenko OA, Caron MJ, Ulema P, Medrano C, Thomas AP, Kimura M, Bonini 3. Werner CM, Hecksteden A, Morsch A, Zundler J, Wegmann M, Kratzsch J, MG, Herbig U, Santos JH. A mutant telomerase defective in nuclear–cytoplasmic Thiery J, Hohl M, Bittenbring JT, Neumann F, Bo ¨ hm M, Meyer T, Laufs U. . shuttling fails to immortalize cells and is associated with mitochondrial dysfunc- Differential effects of endurance, interval, and resistance training on telomerase . tion. Aging Cell 2010;9:203–219. activity and telomere length in a randomized, controlled study. Eur Heart J 2019; 17. Matthews C, Gorenne I, Scott S, Figg N, Kirkpatrick P, Ritchie A, Goddard M, 40:34–46. Bennett M. Vascular smooth muscle cells undergo telomere-based senescence in 4. Werner C, Hanhoun M, Widmann T, Kazakov A, Semenov A, Poss J, Bauersach, . human atherosclerosis: effects of telomerase and oxidative stress. Circ Res 2006; J, Thum T, Pfreundschuh M, Muller P, Haendeler J, Bohm M, Laufs U. Effects of . 99:156–164. physical exercise on myocardial telomere-regulating proteins, survival pathways, 18. Shah A, Gray K, Figg N, Finigan A, Starks L, Bennett M. Defective base excision and apoptosis. J Am Coll Cardiol 2008;52:470–482. . repair of oxidative DNA damage in vascular smooth muscle cells promotes ath- 5. Werner C, Furster T, Widmann T, Poss J, Roggia C, Hanhoun M, Scharhag J, . erosclerosis. Circulation 2018;in press. Buchner N, Meyer T, Kindermann W, Haendeler J, Bohm M, Laufs U. Physical ex- 19. Haycock PC, Heydon EE, Kaptoge S, Butterworth AS, Thompson A, Willeit P. ercise prevents cellular senescence in circulating leukocytes and in the vessel Leucocyte telomere length and risk of cardiovascular disease: systematic review wall. Circulation 2009;120:2438–2447. and meta-analysis. BMJ 2014;349:g4227. 6. Poch E, Carbonell P, Franco S, Diez-Juan A, Blasco MA, Andres V. Short telo- . 20. Brouilette SW, Moore JS, McMahon AD, Thompson JR, Ford I, Shepherd J, meres protect from diet-induced atherosclerosis in apolipoprotein E-null mice. Packard CJ, Samani NJ. Telomere length, risk of coronary heart disease, and sta- FASEB J 2004;18:418–420. tin treatment in the West of Scotland Primary Prevention Study: a nested case– 7. Jakob S, Schroeder P, Lukosz M, Buchner N, Spyridopoulos I, Altschmied J, . control study. Lancet 2007;369:107–114. Haendeler J. Nuclear protein tyrosine phosphatase Shp-2 is one important nega- . 21. De Meyer T, Rietzschel ER, De Buyzere ML, Langlois MR, De Bacquer D, Segers tive regulator of nuclear export of telomerase reverse transcriptase. J Biol Chem P, Van Damme P, De Backer GG, Van Oostveldt P, Van Criekinge W, Gillebert 2008;283:33155–33161. TC, Bekaert S. Systemic telomere length and preclinical atherosclerosis: the 8. Haendeler J, Hoffmann J, Diehl JF, Vasa M, Spyridopoulos I, Zeiher AM, Dimmeler . Asklepios Study. Eur Heart J 2009;30:3074–3081. S. Antioxidants inhibit nuclear export of telomerase reverse transcriptase and 22. Scheller Madrid A, Rode L, Nordestgaard BG, Bojesen SE. Short telomere length delay replicative senescence of endothelial cells. Circ Res 2004;94:768–775. and ischemic heart disease: observational and genetic studies in 290 022 individu- 9. Ahmed S, Passos JF, Birket MJ, Beckmann T, Brings S, Peters H, Birch-Machin . als. Clin Chem 2016;62:1140–1149. MA, von Zglinicki T, Saretzki G. Telomerase does not counteract telomere . 23. TACTIC trial (ISRCTN 16613292). https://doi.org/10.1186/ISRCTN16613292. doi:10.1093/eurheartj/ehy205 Corrigendum Online publish-ahead-of-print 7 April 2018 ................................................................................................ .................................................................. Corrigendum to: CXCL1–CXCR2 axis mediates angiotensin II-induced cardiac hypertrophy and remodelling through regulation of monocyte infiltration [Eur Heart J 2018;39:1818–1831] The authors of the above paper wishes to inform readers that there was an error in figure 5E as first published; this figure has now been cor- rected online. V C Published on behalf of the European Society of Cardiology. All rights reserved. The Author(s) 2018. For permissions, please email: journals.permissions@oup.com. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png European Heart Journal Oxford University Press

Corrigendum to: CXCL1–CXCR2 axis mediates angiotensin II-induced cardiac hypertrophy and remodelling through regulation of monocyte infiltration

European Heart Journal , Volume 40 (1): 1 – Apr 7, 2018
Download PDF
1 page

Loading next page...
 
/lp/ou_press/corrigendum-ca2mBTEv0q
Publisher
Oxford University Press
Copyright
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2018. For permissions, please email: journals.permissions@oup.com.
ISSN
0195-668X
eISSN
1522-9645
DOI
10.1093/eurheartj/ehy205
Publisher site
See Article on Publisher Site

Abstract

Editorial 49 shortening but protects mitochondrial function under oxidative stress. J Cell Sci protection—led to induction of telomerase activity, both its canonic- 2008;121:1046–1053. al (telomere length increase), as well as non-canonical (NO gener- 10. Bennaceur K, Atwill M, Al Zhrany N, Hoffmann J, Keavney B, Breault D, ation) functions. The authors concluded that their study identified Richardson G, von Zglinicki T, Saretzki G, Spyridopoulos I. Atorvastatin induces T cell proliferation by a telomerase reverse transcriptase (TERT) mediated telomerase activity and telomere length as sensitive cellular parame- mechanism. Atherosclerosis 2014;236:312–320. ters to measure preventive effects of exercise interventions. 11. Richardson GD, Sage A, Bennaceur K, Al Zhrany N, Coelho-Lima J, Dookun Although this may be a rather expensive way to monitor the benefi- . E, Draganova L, Saretzki G, Breault DT, Mallat Z, Spyridopoulos I. Telomerase mediates lymphocyte proliferation but not the atherosclerosis- cial exercise effects on the human body, the study findings clearly suppressive potential of regulatory T-cells. Arterioscler Thromb Vasc Biol 2018; underline the advantage of aerobic endurance training compared 38:1283–1296. with resistance training in cardiovascular ageing. . 12. Beyer AM, Freed JK, Durand MJ, Riedel M, Ait-Aissa K, Green P, Hockenberry JC, Morgan RG, Donato AJ, Peleg R, Gasparri M, Rokkas CK, Santos JH, Priel E, Conflict of interest: I.S. receives grants from TA Science New Gutterman DD. Critical role for telomerase in the mechanism of flow-mediated . dilation in the human microcirculation. Circ Res 2016;118:856–866. York. I.S. and K.S. receive fees for being on the regional advisory 13. Sarin KY, Cheung P, Gilison D, Lee E, Tennen RI, Wang E, Artandi MK, Oro AE, board for Bayer. Artandi SE. Conditional telomerase induction causes proliferation of hair follicle stem cells. Nature 2005;436:1048–1052. . 14. Park JI, Venteicher AS, Hong JY, Choi J, Jun S, Shkrel, M, Chang, W, Meng Z, References . Cheung P, Ji H, McLaughlin M, Veenstra TD, Nusse R, McCrea PD, Artandi SE. 1. Ait-Aissa K, Ebben JD, Kadlec AO, Beyer AM. Friend or foe? Telomerase as a Telomerase modulates Wnt signalling by association with target gene chromatin. pharmacological target in cancer and cardiovascular disease. Pharmacol Res 2016; . Nature 2009;460:66–72. 111:422–433. . 15. MaidaY,YasukawaM,FuruuchiM,LassmannT,Possemato R, OkamotoN, 2. Haendeler J, Drose S, Buchner N, Jakob S, Altschmied J, Goy C, Spyridopoulos I, Kasim V, Hayashizaki Y, Hahn WC, Masutomi K. An RNA-dependent RNA Zeiher AM, Brand, U, Dimmeler S. Mitochondrial telomerase reverse transcript- polymerase formed by TERT and the RMRP RNA. Nature 2009;461: ase binds to and protects mitochondrial DNA and function from damage. . 230–235. Arterioscler Thromb Vasc Biol 2009;29:929–935. 16. Kovalenko OA, Caron MJ, Ulema P, Medrano C, Thomas AP, Kimura M, Bonini 3. Werner CM, Hecksteden A, Morsch A, Zundler J, Wegmann M, Kratzsch J, MG, Herbig U, Santos JH. A mutant telomerase defective in nuclear–cytoplasmic Thiery J, Hohl M, Bittenbring JT, Neumann F, Bo ¨ hm M, Meyer T, Laufs U. . shuttling fails to immortalize cells and is associated with mitochondrial dysfunc- Differential effects of endurance, interval, and resistance training on telomerase . tion. Aging Cell 2010;9:203–219. activity and telomere length in a randomized, controlled study. Eur Heart J 2019; 17. Matthews C, Gorenne I, Scott S, Figg N, Kirkpatrick P, Ritchie A, Goddard M, 40:34–46. Bennett M. Vascular smooth muscle cells undergo telomere-based senescence in 4. Werner C, Hanhoun M, Widmann T, Kazakov A, Semenov A, Poss J, Bauersach, . human atherosclerosis: effects of telomerase and oxidative stress. Circ Res 2006; J, Thum T, Pfreundschuh M, Muller P, Haendeler J, Bohm M, Laufs U. Effects of . 99:156–164. physical exercise on myocardial telomere-regulating proteins, survival pathways, 18. Shah A, Gray K, Figg N, Finigan A, Starks L, Bennett M. Defective base excision and apoptosis. J Am Coll Cardiol 2008;52:470–482. . repair of oxidative DNA damage in vascular smooth muscle cells promotes ath- 5. Werner C, Furster T, Widmann T, Poss J, Roggia C, Hanhoun M, Scharhag J, . erosclerosis. Circulation 2018;in press. Buchner N, Meyer T, Kindermann W, Haendeler J, Bohm M, Laufs U. Physical ex- 19. Haycock PC, Heydon EE, Kaptoge S, Butterworth AS, Thompson A, Willeit P. ercise prevents cellular senescence in circulating leukocytes and in the vessel Leucocyte telomere length and risk of cardiovascular disease: systematic review wall. Circulation 2009;120:2438–2447. and meta-analysis. BMJ 2014;349:g4227. 6. Poch E, Carbonell P, Franco S, Diez-Juan A, Blasco MA, Andres V. Short telo- . 20. Brouilette SW, Moore JS, McMahon AD, Thompson JR, Ford I, Shepherd J, meres protect from diet-induced atherosclerosis in apolipoprotein E-null mice. Packard CJ, Samani NJ. Telomere length, risk of coronary heart disease, and sta- FASEB J 2004;18:418–420. tin treatment in the West of Scotland Primary Prevention Study: a nested case– 7. Jakob S, Schroeder P, Lukosz M, Buchner N, Spyridopoulos I, Altschmied J, . control study. Lancet 2007;369:107–114. Haendeler J. Nuclear protein tyrosine phosphatase Shp-2 is one important nega- . 21. De Meyer T, Rietzschel ER, De Buyzere ML, Langlois MR, De Bacquer D, Segers tive regulator of nuclear export of telomerase reverse transcriptase. J Biol Chem P, Van Damme P, De Backer GG, Van Oostveldt P, Van Criekinge W, Gillebert 2008;283:33155–33161. TC, Bekaert S. Systemic telomere length and preclinical atherosclerosis: the 8. Haendeler J, Hoffmann J, Diehl JF, Vasa M, Spyridopoulos I, Zeiher AM, Dimmeler . Asklepios Study. Eur Heart J 2009;30:3074–3081. S. Antioxidants inhibit nuclear export of telomerase reverse transcriptase and 22. Scheller Madrid A, Rode L, Nordestgaard BG, Bojesen SE. Short telomere length delay replicative senescence of endothelial cells. Circ Res 2004;94:768–775. and ischemic heart disease: observational and genetic studies in 290 022 individu- 9. Ahmed S, Passos JF, Birket MJ, Beckmann T, Brings S, Peters H, Birch-Machin . als. Clin Chem 2016;62:1140–1149. MA, von Zglinicki T, Saretzki G. Telomerase does not counteract telomere . 23. TACTIC trial (ISRCTN 16613292). https://doi.org/10.1186/ISRCTN16613292. doi:10.1093/eurheartj/ehy205 Corrigendum Online publish-ahead-of-print 7 April 2018 ................................................................................................ .................................................................. Corrigendum to: CXCL1–CXCR2 axis mediates angiotensin II-induced cardiac hypertrophy and remodelling through regulation of monocyte infiltration [Eur Heart J 2018;39:1818–1831] The authors of the above paper wishes to inform readers that there was an error in figure 5E as first published; this figure has now been cor- rected online. V C Published on behalf of the European Society of Cardiology. All rights reserved. The Author(s) 2018. For permissions, please email: journals.permissions@oup.com.

Journal

European Heart Journal – Oxford University Press

Published: Apr 7, 2018

There are no references for this article.